Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05768347
What this trial is testing

Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC

Who this might be right for
Urothelial CarcinomaNon-Invasive Bladder Urothelial Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 9
Testing effectiveness (Phase 2)Looking for participantsNCT07488676
What this trial is testing

ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 150
Not applicableActive Not RecruitingNCT06366425
What this trial is testing

Screening for Chronic Liver Diseases in General Population

Who this might be right for
Fibrosis, Liver
University Hospital, Montpellier 260
Testing effectiveness (Phase 2)UnknownNCT04099589
What this trial is testing

Neoadjuvant Treatment of Upper Urinary and Muscular Invasive Bladder Urothelial Carcinoma

Who this might be right for
Upper Tract Urinary CarcinomaMuscle-invasive Bladder Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 64
Not applicableApproved For MarketingNCT06877676
What this trial is testing

Pre-Approval Expanded Access Study for TAR-200 Treating Physician Use

Who this might be right for
Non-Muscle Invasive Bladder Neoplasms
Janssen Research & Development, LLC
Not applicableUnknownNCT02895620
What this trial is testing

Effect on Xpert® Bladder Test of Urines Inflammatory Milieu Induced by BCG Treatment of Patients With NMIBC

Who this might be right for
Non Muscle Invasive Bladder CancerTreatment by BCG
Institut Claudius Regaud 24
Not applicableEnded earlyNCT00802711
What this trial is testing

3-Dimensional Conformal Radiation Therapy or Internal Radiation Therapy After Breast-Conserving Surgery in Treating Women With Stage I or Stage II Breast Cancer

Who this might be right for
Breast Cancer
Cancer Trials Ireland 6
Not applicableEnrolling By InvitationNCT07046832
What this trial is testing

Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy

Who this might be right for
OncologyInterventional RadiologyLiver Carcinoma+2 more
MediView XR, Inc. 104
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Early research (Phase 1)Study completedNCT02316171
What this trial is testing

CAVATAK (CVA21) in Non-muscle Invasive Bladder Cancer (VLA-012 CANON)

Who this might be right for
Non-muscle Invasive Bladder Cancer
Viralytics 16
Not applicableStudy completedNCT04601129
What this trial is testing

Advantage of a Fast-recovery Protocol for Minimally Invasive Kidney Surgery

Who this might be right for
Renal Cell Carcinoma
University Hospital, Lille 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05406713
What this trial is testing

Pembrolizumab in Muscle-invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder CarcinomaLocalized CancerUrothelial Carcinoma
Matthew Galsky 46
Not applicableStudy completedNCT05946369
What this trial is testing

Neutrophils to Lymphocytes Ratio in Predicting the Response to BCG in Non-muscle Invasive Bladder Cancer

Who this might be right for
Urinary Bladder CancerUrinary Bladder NeoplasmBCG+2 more
Ain Shams University 96
Post-approval studies (Phase 4)Looking for participantsNCT04790305
What this trial is testing

Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer

Who this might be right for
Carcinoma BreastTriple-negative Breast CancerInvasive Ductal Carcinoma, Breast
Fudan University 1,072
Large-scale testing (Phase 3)Looking for participantsNCT06929286
What this trial is testing

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Memorial Sloan Kettering Cancer Center 125
Not applicableStudy completedNCT00822562
What this trial is testing

Research on Surgery and Micro-Invasive Treatment in Recurrent Primary Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 100
Not applicableUnknownNCT06245759
What this trial is testing

The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients

Who this might be right for
Non-Muscle-Invasive Bladder CancerBladder Cancer
Huazhong University of Science and Technology 120,000
Not applicableWithdrawnNCT00084578
What this trial is testing

Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder

Who this might be right for
Bladder Cancer
Fox Chase Cancer Center
Early research (Phase 1)Active Not RecruitingNCT05483868
What this trial is testing

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder CancerNMIBCNon-Muscle Invasive Bladder Carcinoma+3 more
Aura Biosciences 55
Testing effectiveness (Phase 2)Looking for participantsNCT06704191
What this trial is testing

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

Who this might be right for
Non-Muscle Invasive Bladder CarcinomaStage 0a Bladder Cancer AJCC v8Stage I Bladder Cancer AJCC v8+1 more
Mayo Clinic 40
Next Page